We exist to help commercialize new molecules from 40 years of pent-up plant research by collaborating with world-class research institutions on our platform.
Zea's pipeline of opportunities is ever-expanding and we hope to profoundly impact human health with the Zea Lighthouse platform.
We are evaluating exciting opportunities that touch on a range of diseases, such as:
Hemophilia A & Hemophilia B
Metastatic Colorectal Cancer
Osteoporosis Treatment
Rotavirus Treatment
Artemisinin for Chronic Lyme Disease
Pulmonary Arterial Hypertension
And more.
Our projects are under NDA with our partners, and not published on our website, at this time. To learn more, please contact us.
